InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Wilson Mark Andrew, Directeur Juridique. Insider active across 2 companies, notably NEKTAR THERAPEUTICS. Cumulatively, 22 filings have been recorded. Breakdown: 0 buy · 17 sells. Total volume traded: €253k. Activity tracked since 17 May 2021. The latest transaction was disclosed on 21 November 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Wilson Mark Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,903 shares0Common StockSEC:0001193125-25-297852:0
676 shares@ US$26.59100.0% of flowCommon StockSEC:0000950170-25-110774:0
9,996 shares@ US$0.671.8% of flowCommon StockSEC:0000950170-25-075977:0
11,040 shares@ US$1.013.3% of flowCommon StockSEC:0000950170-25-025040:0
33,402 shares@ US$0.908.9% of flowCommon StockSEC:0000950170-24-140591:0
165,938 shares0Common StockSEC:0000950170-24-137544:0
6,407 shares@ US$1.011.9% of flowCommon StockSEC:0000950170-24-129462:0
5,651 shares@ US$1.282.0% of flowCommon StockSEC:0000950170-24-099353:0
6,260 shares@ US$1.753.1% of flowCommon StockSEC:0000950170-24-062644:0
7,606 shares@ US$0.681.5% of flowCommon StockSEC:0000950170-24-019044:0
7,179 shares@ US$0.491.0% of flowCommon StockSEC:0001209191-23-056183:0
7,221 shares@ US$0.781.6% of flowCommon StockSEC:0001209191-23-046461:0
7,543 shares@ US$0.721.5% of flowCommon StockSEC:0001209191-23-030447:0
8,275 shares@ US$3.007.2% of flowCommon StockSEC:0001209191-23-010954:0
8,690 shares@ US$3.579.2% of flowCommon StockSEC:0001209191-22-057967:0
165,938 shares0Common StockSEC:0001209191-22-046488:0
3,136 shares@ US$3.950.0005% mcap6.4% of flowCommon StockSEC:0001209191-22-029904:0
3,661 shares@ US$10.950.0015% mcap19.1% of flowCommon StockSEC:0001209191-22-011441:0
37,800 shares0Common StockSEC:0001209191-21-070695:0
20,100 shares0Common StockSEC:0001209191-21-065225:0
1,910 shares@ US$13.839.4% of flowCommon StockSEC:0001209191-21-052393:0
1,917 shares@ US$18.3012.1% of flowCommon StockSEC:0001209191-21-034190:0
22 of 22 declarations
About Wilson Mark Andrew
Wilson Mark Andrew is Chief Legal Officer. He has filed 22 filings in total, and across the 22 sampled filings the transactions are sales, with EUR 0 of purchases and EUR 253434 of sales between 2021-05-19 and 2025-11-25 at NEKTAR THERAPEUTICS.
